{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F513ea591-658a-4ead-b909-5fe1416e681c","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Chronic Myeloid Leukemia \u2014 Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/513ea591-658a-4ead-b909-5fe1416e681c\"></iframe>","title":"Chronic Myeloid Leukemia \u2014 Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series","description":"Prof Andreas Hochhaus from Jena University Hospital in Germany, Dr B Douglas Smith from the Sidney Kimmel Comprehensive Cancer Center at John Hopkins in Baltimore, Maryland, and moderator Dr Michael J Mauro from Memorial Sloan Kettering Cancer Center in New York, New York, discuss recent updates on available and novel treatment strategies for chronic myeloid leukemia. Produced by Research To Practice. \r\n\n\nCME information and select publications https://www.researchtopractice.com/ASHCML24 (here).","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/10853e1e-e02f-476e-b923-46623bbcc55c/cover.jpg"}